418 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author정지은-
dc.date.accessioned2019-11-26T06:49:39Z-
dc.date.available2019-11-26T06:49:39Z-
dc.date.issued2019-05-
dc.identifier.citationPHARMACOGENOMICS, v. 20, No. 9, Page. 659-667en_US
dc.identifier.issn1462-2416-
dc.identifier.issn1744-8042-
dc.identifier.urihttps://www.futuremedicine.com/doi/abs/10.2217/pgs-2019-0005-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/114701-
dc.description.abstractAim: This study was designed to identify the possible effects of VEGFA polymorphisms on the occurrence of bleeding complications in patients with mechanical heart valves who have achieved therapeutic international normalized ratio (INR). Materials & methods: 13 SNPs of VEGFA were analyzed. Uni- and multi-variate analyses were conducted to identify associations between polymorphisms and bleeding complications. Results & conclusion: Patients with the CC genotype of rs35410204 had an approximately tenfold higher bleeding complication than those with the T allele. For rs866236, patients who had wild-type homozygotes showed an approximately 2.9-fold higher bleeding complication than C allele carriers. This study demonstrated that bleeding complications during warfarin therapy are associated with VEGFA polymorphisms in patients with mechanical heart valves.en_US
dc.description.sponsorshipThis study was supported by Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education [grant number 2017R1D1A1B03034033]. The authors have no other relevant affiliations or financial involvement with any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in this manuscript apart from those disclosed.en_US
dc.language.isoen_USen_US
dc.publisherFUTURE MEDICINE LTDen_US
dc.subjectbleedingen_US
dc.subjectmechanical heart valveen_US
dc.subjecttherapeutic INRen_US
dc.subjectVEGFAen_US
dc.subjectwarfarinen_US
dc.titleAssociation between VEGFA gene polymorphisms and bleeding complications in patients maintaining therapeutic international normalized ratioen_US
dc.typeArticleen_US
dc.identifier.doi10.2217/pgs-2019-0005-
dc.relation.page6-11-
dc.relation.journalPHARMACOGENOMICS-
dc.contributor.googleauthorYee, Jeong-
dc.contributor.googleauthorKim, Woorim-
dc.contributor.googleauthorChang, Byung Chul-
dc.contributor.googleauthorChung, Lee Eun-
dc.contributor.googleauthorLee, Kyung Eun-
dc.contributor.googleauthorGwak, Hye Sun-
dc.relation.code2019003205-
dc.sector.campusE-
dc.sector.daehakCOLLEGE OF PHARMACY[E]-
dc.sector.departmentDEPARTMENT OF PHARMACY-
dc.identifier.pidjechung-
Appears in Collections:
COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE